Back
Garmin Ltd. 10K Form
Sell
43
GRMN
Garmin Ltd.
Last Price:
$202.14
Seasonality Move:
3.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | GRMN/Garmin Ltd. Quarterly |
| 2024-02-21 | 10K | GRMN/Garmin Ltd. Annual |
| 2023-11-01 | 10Q | GRMN/Garmin Ltd. Quarterly |
| 2023-08-02 | 10Q | GRMN/Garmin Ltd. Quarterly |
| 2023-05-03 | 10Q | GRMN/Garmin Ltd. Quarterly |
| 2023-02-22 | 10K | GRMN/Garmin Ltd. Annual |
Receive GRMN News And Ratings
See the #1 stock for the next 7 days that we like better than GRMN
GRMN Financial Statistics
Sales & Book Value
| Annual Sales: | $6.3B |
|---|---|
| Cash Flow: | $425.1M |
| Price / Cash Flow: | 28.98 |
| Annual Sales: | $44.07 |
| Price / Book: | 4.52 |
Profitability
| EPS (TTM): | 8.11410 |
|---|---|
| Net Income (TTM): | $1.6B |
| Gross Margin: | $3.7B |
| Return on Equity: | 19.57% |
| Return on Assets: | 15.83% |
Garmin Ltd. Earnings Forecast
Key Garmin Ltd. Financial Ratios
-
The Gross Profit Margin over the past 26 years for GRMN is 58.70%.
-
The Selling, General & Administrative Expenses for GRMN have been equal to 17.61% of Gross Profit Margin.
-
The Research & Development expenses have been 15.78% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of GRMN is 22.41% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 18 years.
Garmin Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Household Durables |
| Sector: | Consumer Discretionary |
| Current Symbol: | GRMN |
| CUSIP: | H2906T |
| Website: | garmin.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 3.31 |
| Quick Ratio: | 1.99 |
Price-to-Earnings
| Trailing P/E Ratio: | 27.31 |
|---|---|
| Forward P/E Ratio: | 22.78 |
GRMN Technical Analysis vs Fundamental Analysis
Sell
43
Garmin Ltd. (GRMN)
is a Sell
Is Garmin Ltd. a Buy or a Sell?
-
Garmin Ltd. stock is rated a SellThe current Garmin Ltd. [GRMN] share price is $199.46. The Score for GRMN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.